Key market opportunities in the CDMO sector include rising outsourcing demands for biologics and HPAPIs, driven by R&D costs ...

“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...

Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...

Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...

The market is poised for growth due to rising demand in consumer electronics, AI, IoT, and automotive EVs. Opportunities lie in expanding wafer fabrication, advanced packaging, and testing services.

Key market opportunities for the global small molecule healthcare contract manufacturing sector include increased demand for cost-efficient production, rising outsourcing by pharmaceutical firms, ...

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), and ...

Cellares. Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the ...

Mordor Intelligence has published a new report on the Pharmaceutical Contract Manufacturing Organization (CMO) Market, offering a comprehensive analysis of trends, growth drivers, and future ...

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) -- The transaction is subject to customary closing ...

Resonetics has acquired advanced pulse generator manufacturing assets from Goose Creek-based Med-Ally, the company announced ...

Samsung Biologics is joining hands with the Coalition for Epidemic Preparedness Innovations (CEPI) to strengthen vaccine manufacturing for future ...